Welcome Contact

Email: sales@sex-pharm.com

ADD: 0805, No. 24, Dongming Rd, Xiamen, China.

Fnose--Specifically R&D for heart disease!

Consignment note

  Scott Alba, USA, order No.:SE806901 has been shipped.

  Peter Alexander, USA, order No.:SE806907 has been shipped.

  Darren Brown, GB, order No.:SE806911 has been shipped.

  Yehudi Ben, USA, order No.:SE806942 has been shipped.

  Xavier naidoo, ES, order No.:SE806939 has been shipped.

  Trevor Wright, IT, order No.:SE806969 has been shipped.

  Xavier Scott, USA, order No.:SE806949 has been shipped.

  Wythe Gino, FR, order No.:SE806937 has been shipped.

  Dick Gaby, DE, order No.:SE806958 has been shipped.

  Derrick, DE, order No.:SE807039 has been shipped.

  Xenos Timothy, USA, order No.:SE807136 has been shipped.

  Ximen Vern, USA, order No.:SE807145 has been shipped.

  Udeh Vernon, KR, order No.:SE807255 has been shipped.

  Ulrich Warren, KR, order No.:SE807265 has been shipped.

  Leif Stuart, MY, order No.:SE807368 has been shipped.

  Lynn Randall, MY, order No.:SE807439 has been shipped.

  Louis Patrick, USA, order No.:SE807440 has been shipped.

  Levi Matthew, USA, order No.:SE807521 has been shipped.

  Dana Lorin, USA, order No.:SE807611 has been shipped.

  York green, GB, order No.:SE807739 has been shipped.

Related Products

Body dysmorphic disorder

       Body dysmorphic disorder (BDD) (previously known as Dysmorphophobia is sometimes referred to as body dysmorphia or dysmorphic syndrome) is a (psychological) anxiety disorder in which the affected person is excessively concerned about and preoccupied by a perceived defect in his or her physical features (body image).

        The sufferer may complain of several specific features or a single feature, or a vague feature or general appearance, causing psychological distress that impairs occupational and/or social functioning, sometimes to the point of severe depression and anxiety, development of other anxiety disorders, social withdrawal or complete social isolation, and more. It is estimated that 1–2% of the world's population meet all the diagnostic criteria for BDD (Psychological Medicine, vol 36, p 877).

       The exact cause(s) of BDD differ(s) from person to person. However, most clinicians believe it could be a combination of biological, psychological and environmental factors from their past or present. Abuse can also be a contributing factor.

        Onset of symptoms generally occurs in adolescence or early adulthood, where most personal criticism of one's own appearance usually begins, although cases of BDD onset in children and older adults is not unknown. BDD is often misunderstood to affect mostly women, but research shows that it affects men and women equally.

         The disorder is linked to significantly diminished quality of life and co-morbid major depressive disorder and social phobia. With a completed-suicide rate more than double than that of major depression, and a suicidal ideation rate of around 80%, BDD is considered a major risk factor for suicide.

         A person with the disorder may be treated with psychotherapy, medication, or both. Research has shown cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) to be effective in treating BDD.[citation needed] BDD is a chronic illness and symptoms are likely to persist, or worsen, if left untreated.
 

Back Homepage